Recall

II Ongoing

Cinacalcet Hydrochloride Tablets, 60 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren…

Why: cGMP Deviations: presence of N-nitroso-cinacalcet, above the acceptable daily intake (ADI).

Company
Cipla USA, Inc.
Warren, NJ, United States
Reported
Jul 8, 2026
Recall started
Jun 29, 2026
Where sold
USA Nationwide
Amount
N/A
Full description
Cinacalcet Hydrochloride Tablets, 60 mg, 30-count bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-411-02
Lots / codes affected
Lot #: 5PB0165, 5PB0166, Exp 1/31/2027; 5PB0552, Exp 4/30/2027; 5PB0642, 5PB0643, 5PB0644, Exp 6/30/2027

Class I: could cause serious harm or death. Class II: temporary or treatable problems. Class III: unlikely to cause harm.